UK markets closed

TetraLogic Pharmaceuticals Corporation (TLOG)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.00010.0000 (0.00%)
At close: 04:25PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 458.72k
Enterprise value 458.72k
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)0.40
Enterprise value/revenue N/A
Enterprise value/EBITDA -0.01

Trading information

Stock price history

Beta (5Y monthly) 2.44
52-week change 30.00%
S&P500 52-week change 322.38%
52-week high 30.0001
52-week low 30.0001
50-day moving average 30.0001
200-day moving average 30.0001

Share statistics

Avg vol (3-month) 3N/A
Avg vol (10-day) 3N/A
Shares outstanding 524.47M
Implied shares outstanding 64.59B
Float 821.77M
% held by insiders 10.00%
% held by institutions 10.02%
Shares short (14 Oct 2016) 41.18M
Short ratio (14 Oct 2016) 44.39
Short % of float (14 Oct 2016) 47.12%
Short % of shares outstanding (14 Oct 2016) 44.77%
Shares short (prior month 15 Sept 2016) 41.29M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2015
Most-recent quarter (mrq)30 Sept 2016

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-19.59%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -21.14M
Net income avi to common (ttm)-40.72M
Diluted EPS (ttm)-0.0100
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)5.89M
Total cash per share (mrq)0.24
Total debt (mrq)30.83M
Total debt/equity (mrq)N/A
Current ratio (mrq)0.48
Book value per share (mrq)-1.25

Cash flow statement

Operating cash flow (ttm)-23.88M
Levered free cash flow (ttm)-5.2M